Home » Newsletters » BioWorld Science

BioWorld Science

July 23, 1997

View Archived Issues

Recombinant infertility drug launched in Canada

U.K. approves Astra's treatment for ulcerative colitis

FINFAT multicenter trial results reported at IDF 97

Troglitazone clinical data presented at IDF 97

Problems of insulin supply: insulin turns 75

Novartis prepares orally active iron chelators

Schering AG describes AMPA antagonists

Inhibitors of adhesion molecule expression and TNF release from Novartis

Warner-Lambert describes compounds that modulate signal transduction pathways

TZT-1027 exhibits promising preclinical profile

Pharmacokinetics of S-1 in tumor-bearing animals

Ritipenem acoxil: biliary excretion and efficacy in surgical infections

Interactions between LY-303366 and nikkomycin Z against fungi

Teva's generic antihypertensive combination tentatively approved

Preclinical and clinical results reported for cefluprenam, a new parenteral cephalosporin

Life Medical Sciences discontinues venous stasis ulcer trial

Naratriptan approved in 10 additional European countries

Diabetes: an epidemic for the 21st century

Update on Sugen's SU-101

Hepatic insulin gene expression for treatment of IDDM

Annual Report: Genetronics

Genome Therapeutics and Astra Research Center Boston extend H. pylori alliance

Emitefur: phase II results in breast, gastric and pancreatic cancer

The Immune Response Corp. reports on T-cells involved in psoriasis

IDEC acquires anticancer agent from Pharmacia & Upjohn

Roche licenses patent rights for interferon alfa to Amarillo Biosciences

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.